Director, Pharmacovigilance
Orchard Therapeutics London
Safety expert serving as global PV lead for gene therapy products across investigational and marketed phases, owning benefit-risk strategy, aggregate reports (PSURs, DSURs) and risk management plans. Also acts as medical monitor, providing clinical oversight, real-time AE/SAE review and signal detection in close collaboration with cross-functional teams and health authorities.